Casey Lynch

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Andrew J. Cronauer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Casey Lynch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cortexyme, Inc. Chief Executive Officer, Director Common Stock 978,774 $920,048 $0.9400 18 Nov 2021 By the Zachary and Casey Lynch Living Trust dated February 24, 2009
Cortexyme, Inc. Chief Executive Officer, Director Common Stock 109,895 $103,301 $0.9400 18 Nov 2021 Direct
Cortexyme, Inc. Chief Executive Officer, Director Common Stock 91,911 $86,396 $0.9400 18 Nov 2021 By The Casey C. Lynch 2019 Annuity Trust
Cortexyme, Inc. Chief Executive Officer, Director Stock Option (right to buy) 440,000 03 Jan 2022 Direct
Longboard Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 22,500 23 May 2024 Direct
Longboard Pharmaceuticals, Inc. Director Employee Stock Option (right to buy) 0 02 Dec 2024 Direct

Insider Reports Filed by Casey Lynch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588924028028-lynch-casey-2024-12-02 Longboard Pharmaceuticals, Inc. 02 Dec 2024 5 $0 4 Director 02 Dec 2024, 19:29
/report/000095017024064612-lynch-casey-2024-05-23 Longboard Pharmaceuticals, Inc. 23 May 2024 1 $0 4 Director 24 May 2024, 16:20
/report/000120919123032513-lynch-casey-2023-05-25 Longboard Pharmaceuticals, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 16:13
/report/000120919122032735-lynch-casey-2022-05-24 Longboard Pharmaceuticals, Inc. 24 May 2022 1 $0 4 Director 31 May 2022, 08:29
QNCX Cortexyme, Inc. 03 Jan 2022 1 $0 4 Chief Executive Officer, Director 05 Jan 2022, 16:26
QNCX Cortexyme, Inc. 18 Nov 2021 2 +$27,600 4 Chief Executive Officer, Director 19 Nov 2021, 19:58
QNCX Cortexyme, Inc. 10 May 2021 4 -$1,037,361 4 Chief Executive Officer, Director 12 May 2021, 16:51